Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
about
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Neutrophil-to-lymphocyte ratio ...... definitive chemoradiotherapy.
@en
type
label
Neutrophil-to-lymphocyte ratio ...... definitive chemoradiotherapy.
@en
prefLabel
Neutrophil-to-lymphocyte ratio ...... definitive chemoradiotherapy.
@en
P2093
P2860
P356
P1433
P1476
Neutrophil-to-lymphocyte ratio ...... definitive chemoradiotherapy.
@en
P2093
Chang-Hua Yu
Dong-Cheng He
Guang-Zhou Tao
Wan-Wei Wang
Wei-Guo Zhu
Xi-Lei Zhou
Ya-Qi Song
Yong-Qiang Li
Yu-Suo Tong
P2860
P2888
P356
10.1038/SREP42581
P407
P577
2017-02-14T00:00:00Z